Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Theratechnologies Inc (THTX)

Theratechnologies Inc (THTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Theratechnologies Inc 2015 Peel Street 11th Floor MONTREAL A8 H3A 1T8 CAN

www.theratech.com P: 438-315-6607 F: 514-331-9691

Description:

Theratechnologies, Inc. is a pharmaceutical company focusing on the development of therapeutic peptide products with an emphasis on growth-hormone releasing factor peptides. It's main product EGRIFTA is used for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy which is marketed primarily in the United States, Latin America, Africa, the Middle East, Europe, Russia, South Korea, Taiwan, and Thailand. Theratechnologies, Inc. is headquartered in Montreal, Canada.

Key Statistics

Overview:

Market Capitalization, $K 30,979
Enterprise Value, $K 54,859
Shares Outstanding, K 24,202
Annual Sales, $ 81,760 K
Annual Net Income, $ -23,960 K
Last Quarter Sales, $ 16,250 K
Last Quarter Net Income, $ -4,480 K
EBIT, $ -7,470 K
EBITDA, $ -4,150 K
60-Month Beta 1.41
% of Institutional Shareholders 0.00%
Float, K 24,202
% Float 100.00%
Short Volume Ratio 0.35

Growth:

1-Year Return -65.22%
3-Year Return -90.88%
5-Year Return -93.56%
5-Year Revenue Growth 80.17%
5-Year Earnings Growth -658.33%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.10 on 04/10/24
Latest Earnings Date N/A
Earnings Per Share ttm -0.61
EPS Growth vs. Prev Qtr -25.00%
EPS Growth vs. Prev Year 77.27%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-4 on 07/31/23

THTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -26.15%
Profit Margin % -29.31%
Debt/Equity -2.37
Price/Sales 0.40
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -1.02
Interest Coverage -0.56
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar